Lynn Wenger

Lynn Wenger has over 30 years of experience designing and leading qualitative and quantitative research at RTI. Her research impacts multiple communities, including those who use drugs, service providers, and community stakeholders. Ms. Wenger is skilled in qualitative research design and analysis, quantitative questionnaire development, the oversight of daily implementation of longitudinal research with marginalized populations, and the implementation of online surveys.

Currently Ms. Wenger is a member of the technical team for the evaluation of Oregon's Ballot Measure 110 and Strengthening Syringe Services Programs for People Who Use Drugs. Her additional projects include Assessing the Reach, Effectiveness, and Implementation of Multiple Harm Reduction Interventions (The Moon Study), Methamphetamine Injection, Associated Health Risk, and Causes of Overdose Deaths (The Mars Study), Community Mitigation Against Xylazine (CMAX), and Improving Equitable Access to Naloxone to Prevent Opioid Overdose Deaths within Syringe Services Programs (SAIA Naloxone).

Prior to joining RTI in 2005, Ms. Wenger served as a project director for the University of California, San Francisco, and a project coordinator for the Institute for Scientific Analysis.